138 related articles for article (PubMed ID: 24584175)
21. Dual effects of the antioxidant agents probucol and carvedilol on proliferative and fatty lesions in hypercholesterolemic rabbits.
Donetti E; Soma MR; Barberi L; Paoletti R; Fumagalli R; Roma P; Catapano AL
Atherosclerosis; 1998 Nov; 141(1):45-51. PubMed ID: 9863537
[TBL] [Abstract][Full Text] [Related]
22. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.
Hong SC; Zhao SP; Wu ZH
Int J Cardiol; 2007 Jan; 115(1):29-35. PubMed ID: 16766063
[TBL] [Abstract][Full Text] [Related]
23. [Prevention of atherosclerosis using an antioxidant].
Ishii K; Kita T
Nihon Ronen Igakkai Zasshi; 1990 Mar; 27(2):177-81. PubMed ID: 2384991
[TBL] [Abstract][Full Text] [Related]
24. Treatment with atorvastatin alters the ratio of interleukin-12/interleukin-10 gene expression [corrected].
Naoumova RP; Patel DD; O'Neill FH; Thompson GR; Knight BL
Eur J Clin Invest; 2003 Jan; 33(1):88-91. PubMed ID: 12492458
[TBL] [Abstract][Full Text] [Related]
25. In vivo fluorescence-mediated tomography imaging demonstrates atorvastatin-mediated reduction of lesion macrophages in ApoE-/- mice.
Larmann J; Frenzel T; Schmitz M; Hahnenkamp A; Demmer P; Immenschuh S; Tietge UJ; Bremer C; Theilmeier G
Anesthesiology; 2013 Jul; 119(1):129-41. PubMed ID: 23559030
[TBL] [Abstract][Full Text] [Related]
26. Effects of atorvastatin on expression of ICAM-1 in atherosclerotic rabbits.
Du B; Xu G; Cao H; Cui W; Lin S; Liu Y; Qin L
J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):120-6. PubMed ID: 22609871
[TBL] [Abstract][Full Text] [Related]
27. Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits.
Braesen JH; Beisiegel U; Niendorf A
Virchows Arch; 1995; 426(2):179-88. PubMed ID: 7757289
[TBL] [Abstract][Full Text] [Related]
28. Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbits.
Wang Y; Bai L; Lin Y; Chen Y; Guan H; Zhu N; Li Y; Gao S; Sun L; Zhao S; Fan J; Liu E
Lipids Health Dis; 2015 Jul; 14():82. PubMed ID: 26220196
[TBL] [Abstract][Full Text] [Related]
29. Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits.
O'Brien K; Nagano Y; Gown A; Kita T; Chait A
Arterioscler Thromb; 1991; 11(3):751-9. PubMed ID: 2029510
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of C-reactive protein induced expression of matrix metalloproteinases by atorvastatin in THP-1 cells.
Mahajan N; Dhawan V
Mol Cell Biochem; 2010 May; 338(1-2):77-86. PubMed ID: 20091096
[TBL] [Abstract][Full Text] [Related]
31. Probucol attenuates inflammation and increases stability of vulnerable atherosclerotic plaques in rabbits.
Li T; Chen W; An F; Tian H; Zhang J; Peng J; Zhang Y; Guo Y
Tohoku J Exp Med; 2011 Sep; 225(1):23-34. PubMed ID: 21852751
[TBL] [Abstract][Full Text] [Related]
32. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
[TBL] [Abstract][Full Text] [Related]
33. Probucol-Oxidized Products, Spiroquinone and Diphenoquinone, Promote Reverse Cholesterol Transport in Mice.
Yakushiji E; Ayaori M; Nishida T; Shiotani K; Takiguchi S; Nakaya K; Uto-Kondo H; Ogura M; Sasaki M; Yogo M; Komatsu T; Lu R; Yokoyama S; Ikewaki K
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):591-7. PubMed ID: 26848156
[TBL] [Abstract][Full Text] [Related]
34. Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis.
Fruebis J; Gonzalez V; Silvestre M; Palinski W
Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1289-302. PubMed ID: 9261259
[TBL] [Abstract][Full Text] [Related]
35. [Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits].
Jorge PA; Almeida EA; Ozaki MR; Jorge M; Carneiro A
Arq Bras Cardiol; 2005 Apr; 84(4):314-9. PubMed ID: 15880205
[TBL] [Abstract][Full Text] [Related]
36. Effect of the anti-oxidant probucol on soluble thrombomodulin (sTM) in hypercholesterolemic rabbits.
Hong SC; Zhao SP; Liu Q; Wu ZH
Int J Cardiol; 2008 Jan; 123(2):180-2. PubMed ID: 17292497
[TBL] [Abstract][Full Text] [Related]
37. Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study.
Komukai K; Kubo T; Kitabata H; Matsuo Y; Ozaki Y; Takarada S; Okumoto Y; Shiono Y; Orii M; Shimamura K; Ueno S; Yamano T; Tanimoto T; Ino Y; Yamaguchi T; Kumiko H; Tanaka A; Imanishi T; Akagi H; Akasaka T
J Am Coll Cardiol; 2014 Dec; 64(21):2207-17. PubMed ID: 25456755
[TBL] [Abstract][Full Text] [Related]
38. The thyroid receptor modulator KB3495 reduces atherosclerosis independently of total cholesterol in the circulation in ApoE deficient mice.
Mörk LM; Rehnmark S; Davoodpour P; Norata GD; Larsson L; Witt MR; Malm J; Parini P
PLoS One; 2013; 8(12):e78534. PubMed ID: 24324578
[TBL] [Abstract][Full Text] [Related]
39. Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit--long-term antiatherogenic effect and effects on established plaques.
Nagano Y; Nakamura T; Matsuzawa Y; Cho M; Ueda Y; Kita T
Atherosclerosis; 1992 Feb; 92(2-3):131-40. PubMed ID: 1632845
[TBL] [Abstract][Full Text] [Related]
40. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits.
Mao SJ; Yates MT; Rechtin AE; Jackson RL; Van Sickle WA
J Med Chem; 1991 Jan; 34(1):298-302. PubMed ID: 1992130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
